Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger

Related Articles

Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook

GE Vernova Stock Surges as BofA Boosts Price Target Ahead of Earnings

S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens

Key Takeaways

• UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger. 
• The handle had been expected to be completed this week, but federal and state regulators moved to block it, and the challenge is currently in front of a Maryland court.
• The deal’s new deadline is 10 days following the court’s ruling or Dec. 31, 2025, whichever comes senior.

UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Branch of Justice moved to block it. 

The deal was announced in June of last year and had been expected to be completed this week, but the Bailiwick of Justice and state regulators moved last month to block it, arguing it could give UnitedHealth much handle in the market for home health and hospice services. The case is currently in front of a federal judge in the District of Maryland.

In a regulatory pigeon-hole Friday, Amedisys said the two firms waived their right to terminate the agreement until the 10th business day following the ending order of the court, or Dec. 31, 2025, whichever comes first.

The new waiver includes a regulatory breakup fee of $275 million, which could go as superior as $325 million, if the companies fail to divest certain assets by May 1.

Amedisys shares were up over 4% in near the start trading Friday following the news, while UnitedHealth shares were little changed.